Status:
UNKNOWN
The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial
Lead Sponsor:
Chengfeng Wang
Conditions:
Pancreatic Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial
Detailed Description
The trial is funded by Cancer Foundation of China. The trial is prepared to be registered on the clinicaltrail.gov. Quality assurance plan: every participant is enrolled or excluded by two practiced ...
Eligibility Criteria
Inclusion
- Pancreatectomy patients
Exclusion
- Treated by chemotherapy or radiotherapy before With distant organ metastasis Cannot tolerate surgery
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03398941
Start Date
February 1 2018
End Date
May 1 2019
Last Update
January 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China